These results suggest that tumor heterogeneity may obscure the prognostic value of BAG5 in bulk RNA sequencing datasets, underscoring the need for higher-resolution approaches such as single-cell or spatial transcriptomics in biomarker evaluation. Here, BAG5 is linked to neoplasm.